Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
May 4th, 2015
30K views
A highly reproducible model for myocardial infarction in mice with minimal invasive manipulations is described. The model can be easily performed, resulting in a high reproducibility and survival rate. Thus, the described model will reduce the number of required animals as requested by the 3R principle (Replacement, Refinement and Reduction).
Overview
This article describes a highly reproducible model for inducing myocardial infarction in mice using minimally invasive techniques. The procedure is straightforward, ensuring high survival rates and adherence to the 3R principle.
Key Study Components
Area of Science
- Neuroscience
- Cardiovascular Research
- Animal Models
Background
- Myocardial infarction models are crucial for studying heart disease.
- Minimally invasive techniques can improve animal welfare.
- High reproducibility is essential for reliable research outcomes.
- The 3R principle promotes ethical research practices.
Purpose of Study
- To develop a model that induces myocardial infarction with minimal invasiveness.
- To enhance reproducibility and survival rates in animal studies.
- To provide a technique accessible to researchers with varying experience levels.
Methods Used
- Intubation under a stereo microscope for precise control.
- Creation of a lateral incision to access the thoracic cavity.
- Placement of ligatures on the left descending coronary artery.
- Assessment of infarction size using immunohistochemical analysis.
Main Results
- The model demonstrated high reproducibility and survival rates.
- Minimally invasive techniques facilitated quicker healing.
- Standardized methods allowed for accurate assessment of infarction.
- Results support the ethical reduction of animal use in research.
Conclusions
- This model is a valuable tool for myocardial infarction research.
- It aligns with ethical research practices by minimizing animal use.
- The technique is suitable for researchers with varying skill levels.
Frequently Asked Questions
What is the main advantage of this myocardial infarction model?
The main advantage is its high reproducibility and minimal invasiveness, which enhances animal welfare.
How does this model adhere to the 3R principle?
It reduces the number of animals required for research by ensuring high survival rates and reproducibility.
What techniques are used in this procedure?
The procedure involves intubation, thoracic incision, and ligature placement on the coronary artery.
Is this model suitable for inexperienced researchers?
Yes, the model is designed to be accessible for researchers with minimal experience.
What methods are used to assess the infarction size?
Infarction size is assessed using immunohistochemical analysis and staining techniques.
What type of mice are used in this model?
The model typically uses eight to ten-week-old male C57BL/6 wild type mice.
Executive Industry Relevance
This minimally invasive myocardial infarction model in mice provides a reproducible and ethically aligned system for cardiovascular target validation and mechanistic de-risking. By enabling precise induction of infarction with high survival rates, it supports reliable preclinical assessment of therapeutic candidates. The model addresses the need for disease-relevant systems that reduce biological uncertainty in early discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in a disease-relevant in vivo system.
- Operational Value: Provides a standardized infarct model for consistent target engagement readouts.
- Predictive Value: Supports biological de-risking by linking molecular interventions to functional cardiac outcomes.
Screening & Assay Development
- Scientific Value: Generates quantifiable infarct size metrics via TTC and immunohistochemical staining for compound screening.
- Operational Value: Delivers reproducible histological outputs suitable for assay standardization across studies.
- Predictive Value: Facilitates dose-response analysis and target specificity assessment in infarct models.
Translational & Preclinical Research
- Scientific Value: Models chronic and ischemia-reperfusion infarction to reflect human pathophysiological diversity.
- Operational Value: Enables longitudinal monitoring via echocardiography and terminal histopathology for translational continuity.
- Predictive Value: Supports risk-adjusted advancement decisions by correlating infarct size with functional recovery.
Pipeline & Workflow Integration
The model integrates into the discovery continuum from target validation through preclinical efficacy testing, providing a reproducible platform for cardiovascular lead identification and optimization.
- Discovery Biology: Supports pathway clarification and target validation through controlled infarct induction and functional assessment.
- Screening: Enables standardized compound evaluation via quantifiable infarct size and viability staining.
- Analytics: Provides quantitative dependent variable measurements (infarct %, ejection fraction, fractional shortening) for comparative condition analysis.
- Translational Research: Connects early mechanism to preclinical validation through disease-relevant infarction patterns and biomarker-compatible staining.
- Enterprise Reuse: Establishes a reusable surgical platform for iterative target validation across cardiovascular programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through reproducible infarct models and mechanistic clarity.
- Operational Value: Standardization, reproducibility, and scalability of infarct induction across laboratories.
- Strategic Value: Improved go/no-go decisions via reduced biological variability and enhanced data reliability.
- Portfolio Impact: Risk-based prioritization of candidates using infarct size and functional recovery as decision thresholds.
Implementation Considerations
- Requires microsurgery expertise and stereo microscopy for precise tissue manipulation.
- Dependent on ventilator instrumentation and precise tidal volume/respiration rate control.
- Necessitates standardized ligation techniques and reperfusion protocol adherence for model consistency.
- Requires histology infrastructure for TTC, Evans blue, and immunohistochemical staining.
- Limited by mouse size demanding high precision; mitigated through training and visualization aids.
Biopharma FAQs
Why does infarct size quantification matter for target validation?
Infarct size quantification using TTC staining provides a quantitative dependent variable that enables comparison of therapeutic interventions against ischemic injury, supporting mechanistic de-risking and target confidence assessment.
How does ligation of the left descending coronary artery enable independent variable isolation?
Precise ligature placement on the coronary artery allows isolation of the independent variable (ischemic insult) by controlling infarct location and extent, which is essential for reproducible target validation studies.
What quantitative dependent variable measurements enable preclinical efficacy assessment?
Measurements such as ejection fraction, fractional shortening, and infarct size as a percentage of left ventricular volume provide quantifiable outputs for comparing treatment effects and functional recovery in preclinical models.
Why do replication requirements matter for cross-functional collaboration?
High reproducibility and survival rates ensure consistent infarct generation across sites and teams, enabling reliable data sharing between discovery, preclinical, and translational groups for aligned decision-making.
What statistical analysis capabilities are required before implementing this model?
Implementation requires capability to analyze continuous variables (infarct %, cardiac function) using appropriate statistical tests to compare groups, assess significance, and support go/no-go decisions based on predefined effect thresholds.
